This is a table of type bigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.
bigram | frequency |
---|---|
infected cells | 1166 |
respiratory syndrome | 875 |
amino acid | 716 |
hepatitis virus | 631 |
mouse hepatitis | 567 |
acute respiratory | 486 |
viral rna | 481 |
severe acute | 475 |
amino acids | 438 |
syndrome coronavirus | 374 |
viral replication | 370 |
virus infection | 358 |
vero cells | 350 |
genomic rna | 345 |
type i | 339 |
virus replication | 334 |
rna synthesis | 325 |
murine coronavirus | 319 |
rna polymerase | 311 |
influenza virus | 310 |
cells infected | 301 |
spike protein | 297 |
gene expression | 295 |
porcine reproductive | 294 |
cell surface | 293 |
previously described | 285 |
rna viruses | 281 |
cell lines | 279 |
infectious bronchitis | 277 |
di rna | 273 |
wild type | 272 |
syndrome virus | 265 |
strand rna | 259 |
rna replication | 256 |
bronchitis virus | 255 |
viral proteins | 253 |
cell line | 253 |
transmissible gastroenteritis | 251 |
nucleocapsid protein | 251 |
western blot | 239 |
cord uid | 229 |
virology doi | 229 |
monoclonal antibodies | 229 |
doc id | 229 |
mosaic virus | 221 |
open reading | 216 |
cell fusion | 215 |
structural proteins | 215 |
immune response | 212 |
virus type | 200 |
room temperature | 195 |
cell culture | 195 |
vaccinia virus | 195 |
immunodeficiency virus | 194 |
host cell | 192 |
sequence analysis | 192 |
human coronavirus | 191 |
cell lysates | 189 |
di rnas | 188 |
human immunodeficiency | 187 |
cleavage site | 187 |
described previously | 185 |
rna species | 182 |
nucleotide sequence | 182 |
reading frame | 176 |
three times | 175 |
immune responses | 169 |
molecular weight | 169 |
monoclonal antibody | 168 |
mm tris | 167 |
herpes simplex | 167 |
infectious virus | 165 |
cells expressing | 164 |
blot analysis | 164 |
gastroenteritis virus | 162 |
viral infection | 162 |
simplex virus | 159 |
sars coronavirus | 158 |
gel electrophoresis | 157 |
reverse genetics | 157 |
membrane fusion | 154 |
dbt cells | 153 |
protein expression | 152 |
innate immune | 151 |
plasma membrane | 150 |
membrane protein | 149 |
neutralizing antibodies | 148 |
envelope protein | 148 |
virus entry | 148 |
transfected cells | 146 |
cdna clones | 145 |
tissue culture | 143 |
pcr products | 143 |
virus particles | 142 |
performed using | 141 |
cells transfected | 140 |
kda protein | 140 |
sg rna | 137 |
virus rna | 136 |
porcine epidemic | 132 |
subgenomic mrna | 132 |
rna virus | 131 |
cl pro | 130 |
coronavirus spike | 130 |
hela cells | 129 |
plaque assay | 129 |
viral genome | 129 |
ion channel | 126 |
vesicular stomatitis | 125 |
nervous system | 125 |
infected mice | 123 |
cdna clone | 122 |
acid sequence | 122 |
bovine serum | 121 |
lipid rafts | 120 |
mm nacl | 120 |
stranded rna | 120 |
viral protein | 119 |
time points | 119 |
nonstructural protein | 118 |
mhv infection | 118 |
determine whether | 117 |
subgenomic rna | 116 |
central nervous | 116 |
capsid protein | 116 |
viral envelope | 116 |
cell cultures | 116 |
mg ml | 115 |
agarose gel | 115 |
cell death | 114 |
present study | 114 |
acid residues | 112 |
recombinant viruses | 111 |
middle east | 111 |
infected cell | 111 |
cell cycle | 110 |
epithelial cells | 110 |
epidemic diarrhea | 110 |
diarrhea virus | 109 |
stomatitis virus | 109 |
leader sequence | 108 |
endoplasmic reticulum | 108 |
rna recombination | 107 |
structural protein | 107 |
mm edta | 106 |
results suggest | 106 |
total rna | 106 |
rna transcription | 105 |
cell monolayers | 105 |
well plates | 105 |
envelope glycoprotein | 105 |
dna polymerase | 104 |
fusion protein | 104 |
important role | 104 |
independent experiments | 103 |
reverse transcription | 103 |
electron microscopy | 103 |
murine hepatitis | 102 |
east respiratory | 101 |
novel coronavirus | 101 |
binding protein | 100 |
reading frames | 100 |
dependent rna | 99 |
highly conserved | 99 |
mutant viruses | 99 |
disease virus | 98 |
start site | 98 |
washed three | 97 |
subgenomic mrnas | 97 |
coronavirus infectious | 97 |
sg rnas | 97 |
mice infected | 96 |
plasmid dna | 95 |
expression levels | 95 |
host cells | 95 |
cleavage sites | 95 |
results indicate | 93 |
viral particles | 93 |
taken together | 93 |
virus strain | 93 |
previous studies | 92 |
binding site | 92 |
acid sequences | 92 |
coronavirus infection | 92 |
leader rna | 91 |
reverse transcriptase | 91 |
jhm virus | 91 |
virus production | 91 |
pfu ml | 90 |
coat protein | 90 |
sindbis virus | 90 |
like protease | 89 |
days post | 89 |
coding region | 89 |
cell responses | 89 |
protein synthesis | 89 |
cultured cells | 88 |
respiratory tract | 88 |
dengue virus | 88 |
fever virus | 87 |
rna genome | 87 |
class i | 87 |
consensus sequence | 86 |
rabbit anti | 86 |
bovine coronavirus | 86 |
like proteinase | 85 |
data suggest | 85 |
binding domain | 85 |
transmembrane domain | 85 |
spike glycoprotein | 84 |
feline infectious | 84 |
viral titers | 84 |
infectious peritonitis | 83 |
mhc class | 83 |
target cells | 83 |
pg ml | 83 |
dendritic cells | 82 |
goat anti | 82 |
crystal structure | 82 |
gastroenteritis coronavirus | 82 |
sample buffer | 81 |
western blotting | 81 |
polyacrylamide gel | 81 |
vitro translation | 81 |
virus titers | 81 |
secondary structure | 80 |
coronavirus rna | 80 |
i cells | 79 |
cytoplasmic tail | 79 |
fetal bovine | 79 |
neutralizing antibody | 79 |
life cycle | 78 |
directed mutagenesis | 78 |
recombinant virus | 77 |
overlapping genes | 76 |
host factors | 76 |
closely related | 75 |
mammalian cells | 75 |
mammary tumor | 75 |
pedv infection | 75 |
cov plpro | 75 |
time point | 74 |
cells using | 74 |
subgenomic rnas | 74 |
washed twice | 74 |
may also | 74 |
viral entry | 74 |
influenza viruses | 73 |
three independent | 73 |
expression vector | 73 |
lysis buffer | 72 |
negative control | 72 |
proteolytic processing | 72 |
proteolytic cleavage | 72 |
virus assembly | 72 |
length cdna | 71 |
defective interfering | 71 |
buffered saline | 71 |
replication complex | 71 |
northern blot | 71 |
simian virus | 70 |
nonstructural proteins | 70 |
flow cytometry | 70 |
low ph | 70 |
cleavage products | 69 |
nucleic acid | 69 |
surface expression | 69 |
terminal domain | 69 |
encephalitis virus | 69 |
two different | 69 |
coronavirus replication | 68 |
type ii | 68 |
prrsv infection | 68 |
i i | 68 |
treated cells | 68 |
murine coronaviruses | 68 |
cell types | 68 |
virus genome | 68 |
intracellular rna | 68 |
sucrose gradient | 67 |
receptor binding | 67 |
previously reported | 67 |
transcription initiation | 67 |
like particles | 67 |
i interferon | 67 |
rabies virus | 66 |
even though | 66 |
secondary antibody | 66 |
recombinant vaccinia | 66 |
cov infection | 66 |
cell epitopes | 66 |
coronavirus mhv | 65 |
uninfected cells | 65 |
coronavirus mouse | 65 |
calf serum | 65 |
spinal cord | 65 |
coronavirus nucleocapsid | 65 |
balb cv | 65 |
mrna synthesis | 64 |
cell membrane | 64 |
mrna species | 64 |
ion channels | 64 |
analysis using | 64 |
equine arteritis | 64 |
signaling pathway | 63 |
arteritis virus | 63 |
viral infections | 63 |
jhm strain | 63 |
chain reaction | 62 |
enveloped viruses | 62 |
inhibitory effect | 62 |
mock infected | 62 |
core protein | 62 |
viral rnas | 62 |
active site | 61 |
nsp dc | 61 |
alb ts | 61 |
results showed | 61 |
fusion peptide | 61 |
vitro transcription | 61 |
pcr product | 61 |
class ii | 61 |
respiratory disease | 60 |
polymerase chain | 60 |
terminal region | 60 |
dependent manner | 60 |
avian infectious | 60 |
molecular biology | 60 |
immune system | 60 |
genetics system | 60 |
infectious clone | 60 |
culture medium | 60 |
coronavirus genome | 60 |
bl mice | 60 |
data indicate | 60 |
polyclonal antibody | 60 |
west nile | 59 |
bhk cells | 59 |
acid substitutions | 59 |
sense rna | 59 |
ammonium chloride | 59 |
infectious cdna | 59 |
fusion proteins | 59 |
plaque assays | 59 |
atpase activity | 59 |
virion rna | 58 |
i ifn | 58 |
human coronaviruses | 58 |
sequence similarity | 58 |
may play | 58 |
type virus | 58 |
specific primers | 58 |
hr postinfection | 58 |
untranslated region | 57 |
phylogenetic analysis | 57 |
specific cd | 57 |
subgenomic di | 57 |
cysteine residues | 57 |
membrane vesicles | 57 |
persistently infected | 57 |
tumor virus | 57 |
sialic acid | 56 |
subcellular localization | 56 |
high levels | 56 |
following infection | 56 |
mv vac | 56 |
ts mutants | 56 |
protein gene | 56 |
dna sequencing | 56 |
initiation site | 56 |
specific antibodies | 56 |
binding sites | 56 |
cdna synthesis | 56 |
kindly provided | 55 |
kb rnas | 55 |
nt sequence | 55 |
ribosomal frameshifting | 55 |
alexa fluor | 55 |
cov nsp | 55 |
glycoprotein gene | 55 |
united states | 55 |
many viruses | 55 |
pcr amplification | 55 |
translation initiation | 55 |
time pcr | 55 |
confocal microscopy | 55 |
mrna transcription | 55 |
mouse anti | 55 |
days postinfection | 54 |
mouse igg | 54 |
two proteins | 54 |
expressing cells | 54 |
persistent infection | 54 |
cell entry | 54 |
membrane association | 53 |
coding sequence | 53 |
length ri | 53 |
cell extracts | 53 |
envelope proteins | 53 |
human cytomegalovirus | 53 |
cavv cl | 53 |
growth kinetics | 53 |
ts icv | 53 |
genome sequence | 53 |
measles virus | 53 |
side chains | 53 |
rabbit igg | 52 |
interfering rna | 52 |
horseradish peroxidase | 52 |
golgi apparatus | 52 |
viral antigen | 52 |
genbank accession | 52 |
mrna levels | 52 |
conjugated goat | 52 |
signaling pathways | 52 |
using anti | 51 |
recent studies | 51 |
associated coronavirus | 51 |
golgi complex | 51 |
time rt | 51 |
mutant virus | 51 |
life technologies | 51 |
protein may | 51 |
van der | 51 |
heptad repeat | 51 |
rna transcripts | 51 |
expression system | 51 |
fusion activity | 50 |
stop codon | 50 |
time course | 50 |
final concentration | 50 |
ebola virus | 50 |
cell activation | 50 |
initiation codon | 50 |
significantly higher | 50 |
coronavirus envelope | 50 |
channel activity | 50 |
green fluorescent | 50 |
escherichia coli | 50 |
mhv replication | 50 |
positive cells | 49 |
alveolar type | 49 |
integral membrane | 49 |
pfu cell | 49 |
viral gene | 49 |
determined using | 49 |
jhmv infection | 49 |
santa cruz | 49 |
nile virus | 49 |
gene encoding | 49 |
negative strand | 49 |
restriction sites | 49 |
protein levels | 49 |
human cells | 48 |
viral nucleocapsid | 48 |
hemorrhagic fever | 48 |
cell type | 48 |
specific rna | 48 |
containing mm | 48 |
rna helicase | 48 |
porcine transmissible | 48 |
significant difference | 48 |
sequence alignment | 48 |
nucleic acids | 48 |
secretory pathway | 48 |
control cells | 48 |
like proteases | 48 |
replication complexes | 47 |
per well | 47 |
buffer containing | 47 |
significantly reduced | 47 |
terminal half | 47 |
peritonitis virus | 47 |
northern territory | 47 |
expression plasmids | 47 |
binding activity | 47 |
avian influenza | 47 |
accessory proteins | 47 |
gene products | 47 |
rna interference | 47 |
fluorescent protein | 47 |
mouse mammary | 47 |
cl cells | 47 |
infected vero | 47 |
technical assistance | 47 |
culture supernatants | 46 |
nn cells | 46 |
specific antibody | 46 |
virus strains | 46 |
polymerase activity | 46 |
viral dna | 46 |
lymph nodes | 46 |
brain virus | 46 |
multiple sclerosis | 46 |
also observed | 46 |
wt jhmv | 46 |
adaptive immune | 46 |
previous study | 46 |
pcr using | 46 |
protein interactions | 46 |
nucleotide sequences | 46 |
cells via | 46 |
new world | 46 |
medium containing | 46 |
mouth disease | 46 |
secondary antibodies | 45 |
similar results | 45 |
growth factor | 45 |
statistically significant | 45 |
protein kinase | 45 |
viral glycoprotein | 45 |
huh cells | 45 |
animal model | 45 |
ns protein | 45 |
membrane proteins | 45 |
side chain | 45 |
replicase complex | 45 |
antiviral activity | 45 |
genome replication | 45 |
luciferase activity | 45 |
derm cells | 45 |
sequence data | 45 |
gene product | 45 |
supplementary table | 44 |
polymerase gene | 44 |
swine fever | 44 |
feline coronavirus | 44 |
rna mutants | 44 |
pedv non | 44 |
viral mrna | 44 |
deletion mutants | 44 |
oc nv | 44 |
prrsv helicase | 44 |
protein ion | 44 |
molecular cloning | 44 |
innate immunity | 44 |
gp fr | 44 |
applied biosystems | 44 |
indirect immunofluorescence | 43 |
serine protease | 43 |
matrix protein | 43 |
flanking sequences | 43 |
point mutations | 43 |
ps rna | 43 |
induced apoptosis | 43 |
polyacrylamide gels | 43 |
polyclonal antibodies | 43 |
virus envelope | 43 |
lung tissue | 43 |
cellular receptor | 43 |
infected animals | 43 |
porcine circovirus | 43 |
glial cells | 43 |
agarose gels | 43 |
cytopathic effect | 43 |
african swine | 42 |
primer extension | 42 |
highly pathogenic | 42 |
well plate | 42 |
rna extracted | 42 |
cell spread | 42 |
cov spike | 42 |
veroe cells | 42 |
untreated cells | 42 |
hcv infection | 42 |
semliki forest | 42 |
promoter activity | 42 |
influenza infection | 42 |
rna binding | 42 |
conformational changes | 42 |
complete genome | 42 |
cellular rna | 42 |
intergenic region | 42 |
plaque formation | 42 |
cell epitope | 42 |
hcl ph | 42 |
mrna expression | 42 |
ph gradient | 42 |
host range | 42 |
transcription start | 42 |
mutational analysis | 42 |
cellular proteins | 42 |
nb activation | 41 |
mouse model | 41 |
start codon | 41 |
complement system | 41 |
serum samples | 41 |
mdck cells | 41 |
linked glycosylation | 41 |
membrane permeability | 41 |
rich motif | 41 |
dmem supplemented | 41 |
virion assembly | 41 |
cells treated | 41 |
hydrogen bond | 41 |
protease inhibitor | 41 |
fetal calf | 41 |
mhv strains | 41 |
primers used | 41 |
replicase proteins | 41 |
virus infectivity | 41 |
endothelial cells | 40 |
clinical signs | 40 |
virion envelope | 40 |
ibv strains | 40 |
accession number | 40 |
cord virus | 40 |
african green | 40 |
complete nucleotide | 40 |
envelope glycoproteins | 40 |
leukemia virus | 40 |
virus binding | 39 |
avian coronavirus | 39 |
demyelinating disease | 39 |
stranded dna | 39 |
like domain | 39 |
monkey kidney | 39 |
terminal amino | 39 |
bean mosaic | 39 |
antibody response | 39 |
results demonstrate | 39 |
di particles | 39 |
forest virus | 39 |
mhv rna | 39 |
cek cells | 39 |
bd biosciences | 39 |
sw rotor | 39 |
molecular weights | 39 |
gene sequence | 39 |
cells grown | 39 |
pp ab | 39 |
capsid proteins | 39 |
protein expressed | 39 |
essential medium | 39 |
primary cultures | 39 |
pedv replication | 38 |
viral pathogenesis | 38 |
pk cells | 38 |
mrna degradation | 38 |
lymph node | 38 |
national institutes | 38 |
functional domains | 38 |
st cells | 38 |
conformational change | 38 |
primary antibodies | 38 |
order nidovirales | 38 |
low levels | 38 |
day pi | 38 |
analyzed using | 38 |
respiratory coronavirus | 38 |
enteric coronavirus | 38 |
animal models | 38 |
japanese encephalitis | 38 |
nuclear translocation | 38 |
glycosylation sites | 38 |
cypa ko | 38 |
kda proteins | 38 |
genome organization | 38 |
stem cell | 38 |
primary structure | 37 |
virus titer | 37 |
distantly related | 37 |
cotton rats | 37 |
also present | 37 |
syncytia formation | 37 |
tumor cells | 37 |
sg start | 37 |
unpublished data | 37 |
vlp formation | 37 |
ag ml | 37 |
immunized mice | 37 |
small rnas | 37 |
ts mutant | 37 |
spike gene | 37 |
pbs containing | 37 |
permissive temperature | 37 |
three different | 37 |
ripa buffer | 37 |
mm hepes | 37 |
day post | 36 |
apoptotic cells | 36 |
virus glycoprotein | 36 |
bnip gene | 36 |
signal peptide | 36 |
kidney cells | 36 |
infected possums | 36 |
deduced amino | 36 |
purified virions | 36 |
also found | 36 |
conserved among | 36 |
fatty acid | 36 |
pfbm cells | 36 |
viral antigens | 36 |
transcription factor | 36 |
protease domain | 36 |
complement activation | 36 |
protein palmitoylation | 36 |
discontinuous transcription | 36 |
restriction enzyme | 36 |
southern bean | 36 |
parental virus | 36 |
present within | 36 |
sarcoma virus | 36 |
infectious diseases | 35 |
expression plasmid | 35 |
rabbit polyclonal | 35 |
critical role | 35 |
parental jhm | 35 |
results indicated | 35 |
genomic sequence | 35 |
primer pairs | 35 |
mouse cells | 35 |
spike proteins | 35 |
murine leukemia | 35 |
fipv black | 35 |
protein genes | 35 |
virus release | 35 |
vaccine candidates | 35 |
host defense | 35 |
cu cells | 35 |
pcag nsp | 35 |
serum albumin | 35 |
dmem containing | 35 |
inflammatory cytokines | 35 |
ma cells | 35 |
molecular basis | 35 |
protein encoded | 35 |
plus strand | 35 |
cells may | 35 |
likely due | 35 |
analysis revealed | 35 |
replicon rna | 35 |
viral genomic | 35 |
vero cell | 35 |
sgrna promoters | 34 |
virus nucleocapsid | 34 |
expression level | 34 |
public health | 34 |
differentially expressed | 34 |
wide range | 34 |
gp protein | 34 |
reverse primer | 34 |
virus hemagglutinin | 34 |
main chain | 34 |
molecular mass | 34 |
strain jhm | 34 |
dna viruses | 34 |
type mice | 34 |
expression vectors | 34 |
rna sequence | 34 |
mice immunized | 34 |
insect cells | 34 |
strand synthesis | 34 |
plant viruses | 34 |
helicase activity | 34 |
pdcov nsp | 34 |
primary antibody | 34 |
porcine deltacoronavirus | 34 |
positive strand | 34 |
tgev infection | 33 |
dna vaccine | 33 |
results obtained | 33 |
dead box | 33 |
coronavirus assembly | 33 |
functional receptor | 33 |
antibody titers | 33 |
coronavirus oc | 33 |
culture cells | 33 |
coronavirus associated | 33 |
previously shown | 33 |
positive control | 33 |
assay using | 33 |
replication cycle | 33 |
sequence homology | 33 |
tertiary structure | 33 |
dlsse rna | 33 |
nonpermissive temperature | 33 |
internal initiation | 33 |
mg cells | 33 |
like receptors | 33 |
minor cp | 33 |
rna sequences | 33 |
detected using | 33 |
studies using | 33 |
least three | 33 |
pdm infection | 33 |
signal transduction | 33 |
plant virus | 33 |
specific mab | 33 |
pedv nsp | 33 |
nucleotide substitutions | 33 |
mediated endocytosis | 33 |
protein sequence | 32 |
using primers | 32 |
equine encephalitis | 32 |
viral titer | 32 |
investigate whether | 32 |
data presented | 32 |
genome segments | 32 |
virus adsorption | 32 |
rabbit reticulocyte | 32 |
leader sequences | 32 |
lactate dehydrogenase | 32 |
infection induces | 32 |
group ii | 32 |
charged residues | 32 |
host proteins | 32 |
thermo scientific | 32 |
cells within | 32 |
sucrose cushion | 32 |
barr virus | 32 |
nested set | 32 |
host immune | 32 |
coronavirus gene | 32 |
viral load | 32 |
least two | 32 |
asymmetric evolution | 32 |
viral structural | 32 |
coding sequences | 32 |
new england | 31 |
mm mgcl | 31 |
host response | 31 |
per cell | 31 |
respiratory syncytial | 31 |
enzymatic activity | 31 |
bsr cells | 31 |
intergenic sequence | 31 |
culture supernatant | 31 |
data indicated | 31 |
dna replication | 31 |
enteric tropism | 31 |
erk signaling | 31 |
also detected | 31 |
nsp mutant | 31 |
plasmids encoding | 31 |
bamboo mosaic | 31 |
viral replicase | 31 |
host shutoff | 31 |
genome sequences | 31 |
genome segment | 31 |
cold pbs | 31 |
reticulocyte lysate | 31 |
results show | 31 |
ge healthcare | 31 |
messenger rna | 31 |
translation products | 31 |
rna genomes | 31 |
pcv infection | 31 |
peste des | 31 |
takes place | 31 |
naturally occurring | 31 |
dnase i | 31 |
cellular receptors | 31 |
low level | 31 |
rna packaging | 31 |
viral infectivity | 31 |
forming units | 31 |
may represent | 31 |
protective immunity | 31 |
conjugated anti | 31 |
tm domain | 31 |
fisher scientific | 31 |
mhv nsp | 31 |
petits ruminants | 31 |
different time | 31 |
src inhibition | 31 |
crystal violet | 31 |
cytopathic effects | 31 |
cruz biotechnology | 31 |
phenol chloroform | 31 |
syncytial virus | 31 |
des petits | 31 |
previously identified | 31 |
vitro transcripts | 30 |
packaging signal | 30 |
group coronaviruses | 30 |
genomic organization | 30 |
viral membrane | 30 |
protein forms | 30 |
viral fusion | 30 |
antibodies specific | 30 |
virus expressing | 30 |
two independent | 30 |
pcr analysis | 30 |
iltv infection | 30 |
cells showed | 30 |
significant differences | 30 |
orf protein | 30 |
two distinct | 30 |
helper virus | 30 |
infected bhk | 30 |
sb cells | 30 |
feline calicivirus | 30 |
nuclear localization | 30 |
pcr fragments | 30 |
cell lysate | 30 |
mouse brain | 30 |
semv protease | 30 |
jhmv replication | 30 |
protease inhibitors | 30 |
probably due | 30 |
hcv core | 30 |
protein sequences | 30 |
intracellular transport | 30 |
secondary structures | 30 |
antigenic sites | 29 |
converting enzyme | 29 |
ribosome entry | 29 |
surface antigen | 29 |
mononuclear cells | 29 |
persistent infections | 29 |
apoptotic cell | 29 |
multiple sequence | 29 |
may contribute | 29 |
progenitor cells | 29 |
i ml | 29 |
mouse monoclonal | 29 |
antiviral response | 29 |
sequence identity | 29 |
described elsewhere | 29 |
cytokine production | 29 |
fluorescence microscopy | 29 |
dodecyl sulfate | 29 |
tissue tropism | 29 |
forward primer | 29 |
associated protein | 29 |
protease activity | 29 |
mhv genome | 29 |
viral genomes | 29 |
coronavirus jhm | 29 |
recombination frequency | 29 |
sgrna synthesis | 29 |
accessory protein | 29 |
tobacco mosaic | 29 |
current study | 29 |
newly synthesized | 29 |
complete sequence | 29 |
reporter gene | 29 |
reference virus | 28 |
genomic rnas | 28 |
virus ns | 28 |
cell proliferation | 28 |
two viruses | 28 |
virus isolation | 28 |
helicase protein | 28 |
also shown | 28 |
transgenic mice | 28 |
viral glycoproteins | 28 |
expected size | 28 |
cytoplasmic rna | 28 |
like viruses | 28 |
proteasomal degradation | 28 |
total number | 28 |
confluent monolayers | 28 |
whole cell | 28 |
higher levels | 28 |
binding proteins | 28 |
restriction endonuclease | 28 |
american type | 28 |
murine cells | 28 |
antibody responses | 28 |
sybr green | 28 |
located within | 28 |
nsp protein | 28 |
previous reports | 28 |
protein ic | 28 |
internal ribosome | 28 |
cell response | 28 |
lipid bilayers | 28 |
dromedary camels | 28 |
left panel | 28 |
apparent molecular | 28 |
electrophoretic mobility | 28 |
entry site | 28 |
cxc chemokines | 28 |
green monkey | 28 |
generated using | 28 |
sequences flanking | 28 |
virus spread | 28 |
base pairing | 28 |
type mhv | 28 |
standard deviation | 28 |
viral mrnas | 28 |
cell debris | 28 |
nucleocapsid proteins | 28 |
interfering rnas | 28 |
signal sequence | 28 |
primer pair | 27 |
vitro transcribed | 27 |
ifn response | 27 |
isolated using | 27 |
prrsv replication | 27 |
epidermal growth | 27 |
functional analysis | 27 |
coiled coil | 27 |
intracellular viral | 27 |
genome rna | 27 |
i ifns | 27 |
target cell | 27 |
alveolar macrophages | 27 |
terminal fragment | 27 |
beta interferon | 27 |
reaction mixture | 27 |
virus nonstructural | 27 |
zika virus | 27 |
peripheral blood | 27 |
culture collection | 27 |
regulatory factor | 27 |
first time | 27 |
functional characterization | 27 |
convalescent sera | 27 |
binding affinity | 27 |
hydrogen bonds | 27 |
purified using | 27 |
infect cells | 27 |
virus infections | 27 |
sodium dodecyl | 27 |
serine proteases | 27 |
interferon regulatory | 27 |
permeabilized cells | 27 |
large di | 27 |
wistar furth | 27 |
experimental infection | 27 |
enveloped virus | 27 |
intracellular rnas | 27 |
infectious particles | 27 |
type culture | 27 |
thank dr | 27 |
lipid raft | 27 |
coronavirus transcription | 27 |
nsp mutants | 26 |
productive infection | 26 |
endou activity | 26 |
causative agent | 26 |
gene polyprotein | 26 |
donkey anti | 26 |
infected patients | 26 |
kb rna | 26 |
also showed | 26 |
gradient centrifugation | 26 |
serial dilutions | 26 |
sars virus | 26 |
enter cells | 26 |
electron density | 26 |
chemokine expression | 26 |
may reflect | 26 |
noncoding region | 26 |
catalytic residues | 26 |
heterologous gene | 26 |
gradient electrophoresis | 26 |
per group | 26 |
ii cells | 26 |
inflammatory response | 26 |
oligonucleotide primers | 26 |
temperature sensitive | 26 |
nucleotide sequencing | 26 |
wt virus | 26 |
red clover | 26 |
potato virus | 26 |
indicated time | 26 |
mm sodium | 26 |
cell tropism | 26 |
pam cultures | 26 |
mm dtt | 26 |
post infection | 26 |
clover necrotic | 26 |
wt vsv | 26 |
contains two | 26 |
rubella virus | 26 |
necrotic mosaic | 26 |
san diego | 26 |
benthamiana plants | 26 |
virus proteins | 26 |
viral life | 26 |
homologous recombination | 26 |
rous sarcoma | 26 |
virus particle | 26 |
ex vivo | 26 |
atllf cord | 26 |
culture plates | 26 |
activated protein | 26 |
blocking buffer | 26 |
purified virus | 26 |
neutralizing epitopes | 26 |
hypervariable region | 26 |
vaccine strain | 26 |
neutralizing activity | 25 |
terminal sequence | 25 |
canine coronavirus | 25 |
cell receptor | 25 |
pcr amplified | 25 |
clinical isolates | 25 |
ethidium bromide | 25 |
high frequency | 25 |
least one | 25 |
ifn signaling | 25 |
mve virus | 25 |
rna template | 25 |
dna fragment | 25 |
rna secondary | 25 |
agarose beads | 25 |
cdna cloning | 25 |
immune evasion | 25 |
important roles | 25 |
point mutation | 25 |
cellular protein | 25 |
transfection reagent | 25 |
ng ml | 25 |
terminal sequences | 25 |
obtained using | 25 |
future studies | 25 |
initiation sites | 25 |
viral polymerase | 25 |
water molecule | 25 |
firefly luciferase | 25 |
epithelial cell | 25 |
quantitative real | 25 |
length infectious | 25 |
molecular masses | 25 |
substrate specificity | 25 |
sensitive mutants | 25 |
sars cov | 25 |
following mhv | 25 |
necrosis factor | 25 |
helicase domain | 25 |
premature termination | 25 |
proteins may | 25 |
tumor necrosis | 25 |
hcv replication | 25 |
proteins expressed | 25 |
cell viability | 25 |
host innate | 25 |
large number | 25 |
statistical analysis | 25 |
large rna | 25 |
bamv replicase | 25 |
induced disease | 25 |
coronavirus ibv | 25 |
bone marrow | 25 |
two groups | 25 |
total cellular | 25 |
cysteine protease | 25 |
rna polymerases | 25 |
early stages | 25 |
proteins encoded | 25 |
rv infection | 25 |
fold increase | 25 |
synthetic peptides | 25 |
rna levels | 25 |
essential role | 25 |
deletion mutant | 25 |
transmembrane protein | 25 |
minimal essential | 25 |
virus subgenomic | 25 |
structural basis | 25 |
see materials | 25 |
linked oligosaccharides | 25 |
natural host | 25 |
five times | 25 |
entire genome | 24 |
replicase polyprotein | 24 |
total protein | 24 |
penton base | 24 |
protein coding | 24 |
virus nsp | 24 |
adenovirus type | 24 |
also thank | 24 |
virus capsid | 24 |
induces apoptosis | 24 |
virus maturation | 24 |
progeny virus | 24 |
containing fbs | 24 |
mhv receptor | 24 |
significantly lower | 24 |
cell signaling | 24 |
viral genes | 24 |
rabbit antiserum | 24 |
small envelope | 24 |
cv tumor | 24 |
equal volume | 24 |
interferon production | 24 |
renilla luciferase | 24 |
dna fragments | 24 |
deficient mice | 24 |
small amount | 24 |
cellular membranes | 24 |
high level | 24 |
consensus sequences | 24 |
wt sars | 24 |
major cp | 24 |
virus protein | 24 |
ruminants virus | 24 |
brome mosaic | 24 |
virus stocks | 24 |
cat activity | 24 |
cbp degradation | 24 |
blood cells | 24 |
ev infection | 24 |
dendritic cell | 24 |
family coronaviridae | 24 |
right panel | 24 |
major histocompatibility | 24 |
confocal microscope | 24 |
viral stocks | 24 |
white matter | 24 |
aspartic acid | 24 |
detectable levels | 24 |
widely used | 24 |
movement protein | 24 |
two strains | 24 |
rna elements | 24 |
approximately kda | 24 |
internal entry | 24 |
erk phosphorylation | 24 |
virus stock | 24 |
membrane glycoprotein | 24 |
cell infection | 24 |
incubated overnight | 24 |
like receptor | 24 |
coding regions | 24 |
dna binding | 24 |
recombination events | 24 |
coronavirus strain | 24 |
luciferase activities | 24 |
codon position | 24 |
gene sequences | 24 |
vaccine candidate | 23 |
acid binding | 23 |
atllf brain | 23 |
prrsv gp | 23 |
plasmids expressing | 23 |
evidence suggests | 23 |
ddx knockdown | 23 |
protein interacts | 23 |
sgrna promoter | 23 |
protein ns | 23 |
experimentally infected | 23 |
interfering particles | 23 |
venezuelan equine | 23 |
transcription factors | 23 |
glass coverslips | 23 |
aa substitutions | 23 |
leaky scanning | 23 |
statistical significance | 23 |
encephalomyelitis virus | 23 |
gc qr | 23 |
rna templates | 23 |
triphosphatase activity | 23 |
cdna fragments | 23 |
frameshift mutations | 23 |
porcine respiratory | 23 |
amplified using | 23 |
replication kinetics | 23 |
multisystemic wasting | 23 |
complex formation | 23 |
infectious viral | 23 |
polymerase promoter | 23 |
dependent endocytosis | 23 |
loop structure | 23 |
yeast two | 23 |
mrna decay | 23 |
copy numbers | 23 |
copy number | 23 |
protein vp | 23 |
studies suggest | 23 |
pa segment | 23 |
immune complexes | 23 |
infectious virions | 23 |
thermo fisher | 23 |
infected ccl | 23 |
coronavirus replicase | 23 |
animal care | 23 |
two major | 23 |
basic amino | 23 |
much lower | 23 |
weight loss | 23 |
acute encephalitis | 23 |
acid identity | 23 |
muns processing | 23 |
bsmv sgrna | 23 |
clinical disease | 23 |
hiv entry | 23 |
molecular mechanisms | 23 |
serial passages | 23 |
protein interaction | 23 |
ribosomal entry | 23 |
molecular probes | 23 |
north american | 23 |
medium supplemented | 23 |
cell infiltration | 23 |
may provide | 23 |
co i | 23 |
also used | 23 |
cleavage product | 22 |
commercially available | 22 |
pcr kit | 22 |
supplementary data | 22 |
tyrosine kinase | 22 |
using two | 22 |
free dmem | 22 |
laboratory manual | 22 |
small plaque | 22 |
two regions | 22 |
recombinant protein | 22 |
growth properties | 22 |
virus isolates | 22 |
analysis showed | 22 |
hybrid cells | 22 |
comparative analysis | 22 |
infected neurons | 22 |
polypyrimidine tract | 22 |
modulatory effect | 22 |
old world | 22 |
genetic analysis | 22 |
immunofluorescence microscopy | 22 |
surface glycoprotein | 22 |
neural progenitor | 22 |
transgenic plants | 22 |
culture fluid | 22 |
laemmli sample | 22 |
anpep ko | 22 |
hydrophobic residues | 22 |
small molecule | 22 |
host factor | 22 |
internal control | 22 |
immunized animals | 22 |
horse sickness | 22 |
stem cells | 22 |
mini kit | 22 |
situ hybridization | 22 |
yellow fever | 22 |
plasmids containing | 22 |
type jhm | 22 |
findings suggest | 22 |
sense primer | 22 |
tissue samples | 22 |
lelystad virus | 22 |
different times | 22 |
coronavirus nsp | 22 |
binding pocket | 22 |
inactivated virus | 22 |
fusion peptides | 22 |
equal amounts | 22 |
selection pressure | 22 |
rd cells | 22 |
loading buffer | 22 |
various times | 22 |
viral particle | 22 |
sorting signal | 22 |
cell membranes | 22 |
distilled water | 22 |
peplomer protein | 22 |
largest rna | 22 |
luciferase reporter | 22 |
core sequence | 22 |
proteolytic activation | 22 |
mapk pathway | 22 |
nude mice | 22 |
cell adhesion | 22 |
protein function | 22 |
ns proteins | 22 |
examined whether | 22 |
viral growth | 22 |
fluorescence microscope | 22 |
basic residues | 22 |
systemic infection | 22 |
associated virus | 22 |
rna extraction | 22 |
yellow mosaic | 22 |
intestinal mucosa | 22 |
linked glycoproteins | 22 |
immune cells | 22 |
biological properties | 22 |
calculated using | 21 |
african horse | 21 |
reduced viral | 21 |
anthrax pa | 21 |
sendai virus | 21 |
terminal tail | 21 |
conjugated secondary | 21 |
may affect | 21 |
standard deviations | 21 |
acid changes | 21 |
viral families | 21 |
protein binds | 21 |
small intestine | 21 |
also possible | 21 |
protein structure | 21 |
coronavirus group | 21 |
antiviral effects | 21 |
three groups | 21 |
excellent technical | 21 |
high degree | 21 |
indel strain | 21 |
arterivirus nsp | 21 |
virus neutralization | 21 |
furth rats | 21 |
error bars | 21 |
primary sequence | 21 |
labeled rna | 21 |
host interactions | 21 |
molecular characterization | 21 |
virus characterization | 21 |
results presented | 21 |
like cells | 21 |
viral capsid | 21 |
poliovirus rna | 21 |
test whether | 21 |
possible explanation | 21 |
neutral ph | 21 |
replication within | 21 |
different mechanisms | 21 |
positively charged | 21 |
cap structure | 21 |
phosphate buffer | 21 |
hk protein | 21 |
upper respiratory | 21 |
wasting syndrome | 21 |
efficient replication | 21 |
beckman sw | 21 |
pathogenic avian | 21 |
fold higher | 21 |
dhori virus | 21 |
alkaline phosphatase | 21 |
channel conductance | 21 |
previous findings | 21 |
circovirus type | 21 |
red blood | 21 |
nuclear factor | 21 |
terminal end | 21 |
sequence comparison | 21 |
cellular immune | 21 |
high titers | 21 |
hcv rna | 21 |
van dinten | 21 |
studies demonstrated | 21 |
chloroalkyl ketones | 21 |
solution containing | 21 |
antisense primer | 21 |
containing rna | 21 |
coronavirus nonstructural | 21 |
two separate | 21 |
prrsv nsp | 21 |
rna structure | 21 |
pcr assay | 21 |
avian reovirus | 21 |
virus gene | 21 |
weight markers | 21 |
metabolically labeled | 21 |
i interferons | 21 |
fresh medium | 21 |
genome expression | 21 |
gene block | 21 |
culture media | 21 |
protein translation | 21 |
rub genome | 21 |
containing viruses | 21 |
one hour | 21 |
variant viruses | 21 |
chemokine receptor | 21 |
standard virus | 21 |
early stage | 21 |
two amino | 21 |
hemagglutinin esterase | 21 |
adhesion molecule | 20 |
rna fragments | 20 |
hong kong | 20 |
protein might | 20 |
viral components | 20 |
feline coronaviruses | 20 |
cells without | 20 |
containing vesicles | 20 |
lethal infection | 20 |
protein products | 20 |
polyclonal anti | 20 |
cov replicon | 20 |
noncoding rna | 20 |
full length | 20 |
recent study | 20 |
inhibitor cocktail | 20 |
replicase gene | 20 |
signaling cascade | 20 |
negatively charged | 20 |
mediated cleavage | 20 |
cell movement | 20 |
shrna expression | 20 |
cov replication | 20 |
acid substitution | 20 |
barley stripe | 20 |
partially purified | 20 |
virus large | 20 |
proinflammatory cytokines | 20 |
genetics systems | 20 |
adaptive immunity | 20 |
specific mrna | 20 |
virus fusion | 20 |
mm na | 20 |
human herpesviruses | 20 |
ko pigs | 20 |
viruses including | 20 |
strand cdna | 20 |
repeat region | 20 |
plaque purified | 20 |
cmv promoter | 20 |
potential role | 20 |
body junction | 20 |
triple gene | 20 |
structural genes | 20 |
data demonstrate | 20 |
associated proteins | 20 |
ibv infection | 20 |
neurotropic coronavirus | 20 |
viral spread | 20 |
adenoviral vaccine | 20 |
mhv strain | 20 |
monoclonal anti | 20 |
slippery sequence | 20 |
viruses containing | 20 |
dna fragmentation | 20 |
mhv transcription | 20 |
proteolytic activity | 20 |
coronavirus infections | 20 |
saudi arabia | 20 |
binding motif | 20 |
direct interaction | 20 |
pol zn | 20 |
virus species | 20 |
precursor protein | 20 |
histocompatibility complex | 20 |
two additional | 20 |
lymphocytic choriomeningitis | 20 |
purified genome | 20 |
also known | 20 |
plasmid containing | 20 |
sepharose beads | 20 |
small interfering | 20 |
nb pathway | 20 |
intracellular membranes | 20 |
like protein | 20 |
coronaviridae family | 20 |
virion proteins | 20 |
tomrsv rna | 20 |
cells per | 20 |
guinea pig | 20 |
rat alveolar | 20 |
encoded proteins | 20 |
membrane rearrangement | 20 |
negative controls | 20 |
intergenic regions | 20 |
quantitative rt | 19 |
relatively low | 19 |
ko cell | 19 |
hepatitis viruses | 19 |
cells well | 19 |
measured using | 19 |
strain bcv | 19 |
polyadenylation activity | 19 |
transient expression | 19 |
protein contains | 19 |
peplomer gene | 19 |
mouse cd | 19 |
well understood | 19 |
jev replication | 19 |
significantly increased | 19 |
may occur | 19 |
media containing | 19 |
infectious rna | 19 |
fold change | 19 |
enteric disease | 19 |
rna molecules | 19 |
uranyl acetate | 19 |
much less | 19 |
coronavirus cl | 19 |
national institute | 19 |
specific proteins | 19 |
inhibitory activity | 19 |
mhvr cells | 19 |
facs analysis | 19 |
neuronal cells | 19 |
immunofluorescence assays | 19 |
mutations within | 19 |
residues within | 19 |
mm pmsf | 19 |
ergic golgi | 19 |
carcinoembryonic antigen | 19 |
pattern recognition | 19 |
primer sequences | 19 |
fcwf cells | 19 |
dimensional gel | 19 |
specific rnas | 19 |
citrus tristeza | 19 |
dna synthesis | 19 |
tcid ml | 19 |
oc tc | 19 |
group coronavirus | 19 |
human adenovirus | 19 |
system based | 19 |
ha protein | 19 |
length transcripts | 19 |
acting rna | 19 |
nucleocapsid gene | 19 |
amino terminal | 19 |
significantly inhibited | 19 |
previous report | 19 |
peptidyl chloroalkyl | 19 |
substrate binding | 19 |
increased expression | 19 |
stably expressing | 19 |
two domains | 19 |
tegument protein | 19 |
significantly different | 19 |
negative staining | 19 |
helicase ddx | 19 |
significant reduction | 19 |
internal ribosomal | 19 |
using monoclonal | 19 |
also reported | 19 |
serial passage | 19 |
reprint requests | 19 |
enzymatic activities | 19 |
cells labeled | 19 |
ribosomal frameshift | 19 |
protein induces | 19 |
stripe mosaic | 19 |
i cell | 19 |
cells isolated | 19 |
dna sequence | 19 |
different regions | 19 |
antigen presentation | 19 |
kb fragment | 19 |
pandemic influenza | 19 |
primed transcription | 19 |
single amino | 19 |
cysteine proteases | 19 |
permeabilizing activity | 19 |
containing fetal | 19 |
bal fluid | 19 |
using trizol | 19 |
vaccine vectors | 19 |
gp ep | 19 |
olfactory bulb | 19 |
porcine aminopeptidase | 19 |
syncytium formation | 19 |
replicase polyproteins | 19 |
glycosylation site | 19 |
atlie brain | 19 |
specific intracellular | 19 |
remains unclear | 19 |
indicated times | 19 |
pdcov infection | 19 |
mhv di | 19 |
dna vaccines | 19 |
disease progression | 19 |
plaque reduction | 19 |
rk cells | 19 |
host gene | 19 |
virus vectors | 19 |
marburg virus | 19 |
cells inoculated | 19 |
conserved sequence | 18 |
virus recovery | 18 |
state university | 18 |
virus taxonomy | 18 |
subgenomic ris | 18 |
possible role | 18 |
major structural | 18 |
alpha beta | 18 |
previously published | 18 |
pigs infected | 18 |
pivotal role | 18 |
rna containing | 18 |
cellular factors | 18 |
induced cell | 18 |
infected cultures | 18 |
infectious viruses | 18 |
predicted cleavage | 18 |
gp ecto | 18 |
viral variants | 18 |
mm dishes | 18 |
sodium deoxycholate | 18 |
result suggests | 18 |
nucleotide positions | 18 |
coronavirus transmissible | 18 |
ci mmol | 18 |
zinc finger | 18 |
phylogenetic analyses | 18 |
virus isolated | 18 |
bovine enteric | 18 |
predicted amino | 18 |
body trs | 18 |
one possible | 18 |
similar levels | 18 |
nt fragment | 18 |
also contains | 18 |
antiviral responses | 18 |
expressing plasmids | 18 |
restriction site | 18 |
england biolabs | 18 |
expressing sars | 18 |
erk activation | 18 |
mek erk | 18 |
pcv replication | 18 |
rna products | 18 |
data associated | 18 |
human rhinovirus | 18 |
biologically active | 18 |
weeks post | 18 |
specific sequences | 18 |
assay kit | 18 |
alveolar epithelial | 18 |
cells seeded | 18 |
nsp may | 18 |
pathogenic properties | 18 |
ifn antagonists | 18 |
electron microscopic | 18 |
nuclear pore | 18 |
critical roles | 18 |
derived vectors | 18 |
ntpase activity | 18 |
golgi membranes | 18 |
using lipofectamine | 18 |
different species | 18 |
pdm influenza | 18 |
serially diluted | 18 |
cell lysis | 18 |
performed according | 18 |
influenza hemagglutinin | 18 |
bhk mceacam | 18 |
jackson immunoresearch | 18 |
recombinant plasmids | 18 |
like virus | 18 |
human cd | 18 |
rna segment | 18 |
stunt virus | 18 |
infected sb | 18 |
electron microscope | 18 |
viral assembly | 18 |
also examined | 18 |
intracellular localization | 18 |
independent translation | 18 |
replicase products | 18 |
conserved regions | 18 |
online version | 18 |
direct evidence | 18 |
infected dbt | 18 |
plaque purification | 18 |
cloned cdna | 18 |
fluorescence intensity | 18 |
human papillomavirus | 18 |
tumor antigen | 18 |
nitric oxide | 18 |
nuclear import | 18 |
living cells | 18 |
length negative | 18 |
virus yields | 18 |
polyprotein processing | 18 |
growth curves | 18 |
high titer | 18 |
virus growth | 18 |
specific primer | 18 |
separate experiments | 18 |
cell clones | 18 |
polymerase ii | 18 |
planar lipid | 18 |
host protein | 18 |
human monoclonal | 18 |
protein complexes | 18 |
chemokine receptors | 18 |
nitrocellulose membrane | 18 |
cell attachment | 18 |
cov infected | 18 |
transformed cells | 18 |
infectious entry | 18 |
experiments using | 18 |
cytoplasmic tails | 18 |
precursor proteins | 18 |
human herpesvirus | 18 |
induce apoptosis | 18 |
rneasy mini | 18 |
ul usp | 18 |
domain architecture | 18 |
low pathogenic | 18 |
plasmid encoding | 18 |
like particle | 18 |
liquid scintillation | 18 |
ri rna | 18 |
two sites | 18 |
mosaic potexvirus | 18 |
coronavirus tgev | 18 |
intestinal epithelial | 18 |
biological functions | 18 |
results suggested | 18 |
facs buffer | 18 |
mononuclear cell | 18 |
determined whether | 18 |
viral proteinases | 18 |
final extension | 18 |
sam binding | 18 |
group i | 18 |
severe disease | 17 |
trichosurus vulpecula | 17 |
egfp expression | 17 |
assembly sites | 17 |
van marle | 17 |
carboxy terminus | 17 |
minus strand | 17 |
divalent cations | 17 |
virion production | 17 |
atiif cord | 17 |
induced ifn | 17 |
mass spectrometry | 17 |
catalytic activity | 17 |
virus core | 17 |
chicken embryo | 17 |
neutralization assay | 17 |
virus preparations | 17 |
encoded proteinases | 17 |
clinical symptoms | 17 |
common marmosets | 17 |
infectious agents | 17 |
coterminal nested | 17 |
four hours | 17 |
examined using | 17 |
trizol reagent | 17 |
sucrose gradients | 17 |
blood samples | 17 |
expression strategy | 17 |
containing subgenomic | 17 |
infected plants | 17 |
sf cells | 17 |
free medium | 17 |
using specific | 17 |
viral progeny | 17 |
virus date | 17 |
onto nitrocellulose | 17 |
transmission electron | 17 |
large tumor | 17 |
cells present | 17 |
indel infection | 17 |
binding region | 17 |
polymerase proteins | 17 |
intermediate cleavage | 17 |
infectious disease | 17 |
results demonstrated | 17 |
postweaning multisystemic | 17 |
cc chemokine | 17 |
late times | 17 |
antibodies directed | 17 |
structural studies | 17 |
cells co | 17 |
real time | 17 |
expressing egfp | 17 |
specific monoclonal | 17 |
gel containing | 17 |
kinase activity | 17 |
induce cell | 17 |
intracellular ifn | 17 |
mutagenesis kit | 17 |
like proteinases | 17 |
blot hybridization | 17 |
cell hybrids | 17 |
lysates prepared | 17 |
contact pigs | 17 |
protective antigen | 17 |
mice deficient | 17 |
transiently transfected | 17 |
acid metabolism | 17 |
various concentrations | 17 |
hiv infection | 17 |
trypsin treatment | 17 |
glycoprotein gp | 17 |
lower respiratory | 17 |
antibody conjugated | 17 |
fusion assay | 17 |
virus induces | 17 |
play important | 17 |
ic activity | 17 |
ross river | 17 |
specific interaction | 17 |
uv irradiation | 17 |
infectious dose | 17 |
mapk activation | 17 |
genomic sequences | 17 |
tg mice | 17 |
genomic di | 17 |
unpublished observations | 17 |
phase transition | 17 |
ifn production | 17 |
bushy stunt | 17 |
predicted molecular | 17 |
mammalian expression | 17 |
hcv entry | 17 |
live cells | 17 |
intact cells | 17 |
among coronaviruses | 17 |
vaccine vector | 17 |
major capsid | 17 |
considered significant | 17 |
rat serum | 17 |
minimum essential | 17 |
protein stability | 17 |
human respiratory | 17 |
endocytic pathway | 17 |
unpublished results | 17 |
nucleotide differences | 17 |
fusion site | 17 |
enveloped rna | 17 |
control possums | 17 |
binding motifs | 17 |
standard curve | 17 |
kcal mol | 17 |
porcine alveolar | 17 |
crossover sites | 17 |
two sets | 17 |
crystal structures | 17 |
virus attachment | 17 |
infection cycle | 17 |
tristeza virus | 17 |
codon usage | 17 |
tomato bushy | 17 |
speed centrifugation | 17 |
control group | 17 |
gene coding | 17 |
cymv grna | 17 |
choriomeningitis virus | 17 |
rnadependent rna | 17 |
pveer expression | 17 |
cells stably | 17 |
cells incubated | 17 |
viral clearance | 17 |
pcr fragment | 17 |
nicotiana benthamiana | 17 |
neutralizing mabs | 17 |
following viral | 17 |
heptad repeats | 17 |
replicon cell | 17 |
reverse genetic | 17 |
inactivated fetal | 17 |
plaque forming | 17 |
live attenuated | 17 |
inducing factor | 17 |
specific cellular | 17 |
rna interactions | 16 |
subsequent experiments | 16 |
expressed alone | 16 |
membrane rearrangements | 16 |
rna helicases | 16 |
novel human | 16 |
genetic recombination | 16 |
baby hamster | 16 |
virus families | 16 |
may contain | 16 |
template rna | 16 |
cell proteases | 16 |
prepared using | 16 |
pseudoknot structure | 16 |
might also | 16 |
virulent strain | 16 |
viral proteases | 16 |
surface protein | 16 |
ko clones | 16 |
igg antibody | 16 |
jhm infection | 16 |
two large | 16 |
translational control | 16 |
hepatitis coronavirus | 16 |
repeat regions | 16 |
specific cdna | 16 |
positive samples | 16 |
dominant negative | 16 |
plaque morphology | 16 |
also contribute | 16 |
membrane cholesterol | 16 |
glutamic acid | 16 |
wt vol | 16 |
immunofluorescence assay | 16 |
well tissue | 16 |
glycoprotein el | 16 |
cns cells | 16 |
hela cell | 16 |
viruses formed | 16 |
producing cells | 16 |
den boon | 16 |
different cell | 16 |
may explain | 16 |
experiments showed | 16 |
cycle progression | 16 |
coronavirus genomes | 16 |
dub activity | 16 |
puuv gn | 16 |
arterivirus replicase | 16 |
i fipv | 16 |
chick embryo | 16 |
cell survival | 16 |
antibodies used | 16 |
rna recombinant | 16 |
protein families | 16 |
nuclear export | 16 |
biochemical characterization | 16 |
virus movement | 16 |
rat anti | 16 |
hcv ns | 16 |
detection system | 16 |
lymphocyte responses | 16 |
neutralizing monoclonal | 16 |
days pi | 16 |
rabbit antibody | 16 |
six subgenomic | 16 |
two times | 16 |
protein domains | 16 |
cat gene | 16 |
host antiviral | 16 |
nte buffer | 16 |
hemagglutinating encephalomyelitis | 16 |
virus infected | 16 |
petri dishes | 16 |
buoyant density | 16 |
rna degradation | 16 |
antiviral protein | 16 |
viral multiplication | 16 |
regulated genes | 16 |
rna silencing | 16 |
noncoding rnas | 16 |
ccl mice | 16 |
indel strains | 16 |
cycling conditions | 16 |
phosphorylation sites | 16 |
mhv particles | 16 |
also demonstrated | 16 |
cl cell | 16 |
inhibitory effects | 16 |
previously demonstrated | 16 |
enteric ad | 16 |
two copies | 16 |
virus cell | 16 |
based peptides | 16 |
inoculated onto | 16 |
rna molecule | 16 |
different concentrations | 16 |
pfu per | 16 |
prrsv strain | 16 |
mem containing | 16 |
demyelination induced | 16 |
gene modulation | 16 |
translation product | 16 |
vectors expressing | 16 |
mhv polymerase | 16 |
infection may | 16 |
cov vlps | 16 |
innate antiviral | 16 |
times postinfection | 16 |
dependent sorting | 16 |
targeting shrna | 16 |
elevating virus | 16 |
dc virus | 16 |
first step | 16 |
amersham biosciences | 16 |
intranasal inoculation | 16 |
membrane fraction | 16 |
cells identification | 16 |
protein nsp | 16 |
lmh cells | 16 |
specific antisera | 16 |
protein antibody | 16 |
human liver | 16 |
enhanced green | 16 |
strand rnas | 16 |
acidic ph | 16 |
epidemic diarrhoea | 16 |
rnase protection | 16 |
acting element | 16 |
immediately downstream | 16 |
replication transcription | 16 |
sg mrna | 16 |
see table | 16 |
previous results | 16 |
cynomolgus monkeys | 16 |
lower levels | 16 |
washed times | 16 |
targeted rna | 16 |
bd pharmingen | 16 |
hr helix | 16 |
may result | 16 |
recently reported | 16 |
several viruses | 16 |
eagle medium | 16 |
grand island | 16 |
ucuaa repeats | 16 |
transcription consensus | 16 |
cxc chemokine | 16 |
protein inhibits | 16 |
high mortality | 16 |
immediately upstream | 16 |
times post | 16 |
human bst | 16 |
virus spike | 16 |
equal amount | 16 |
conserved motifs | 16 |
gfp expression | 16 |
foster city | 16 |
viral production | 16 |
prion protein | 16 |
oc infection | 16 |
recombination frequencies | 16 |
human embryonic | 16 |
ddx shrna | 16 |
direct sequencing | 16 |
foreign gene | 16 |
virus nucleoprotein | 16 |
amersham pharmacia | 16 |
host species | 16 |
mv bulk | 16 |
protein bands | 16 |
compare lanes | 16 |
one possibility | 16 |
various time | 16 |
kda polypeptide | 16 |
egfp orf | 16 |
oligonucleotide probes | 16 |
deletions within | 16 |
per milliliter | 16 |
independent infection | 16 |
cellular processes | 16 |
one set | 16 |
constructed using | 16 |
antibody specific | 16 |
viral yield | 16 |
antiviral effect | 16 |
parental viruses | 16 |
new insights | 15 |
quantitative pcr | 15 |
modified eagle | 15 |
sequence requirements | 15 |
sars patients | 15 |
previous work | 15 |
viral sequences | 15 |
vitro assembly | 15 |
vector expressing | 15 |
mice undergoing | 15 |
boehringer mannheim | 15 |
results strongly | 15 |
conserved region | 15 |
recombinant ad | 15 |
vitro studies | 15 |
approximately kb | 15 |
host mrna | 15 |
neurological disease | 15 |
plaque size | 15 |
protein processing | 15 |
using either | 15 |
animal viruses | 15 |
four times | 15 |
frameshift mutation | 15 |
driven cell | 15 |
kind gift | 15 |
leader trs | 15 |
structural polypeptides | 15 |
surface receptors | 15 |
mhv genomic | 15 |
nucleotide changes | 15 |
unique restriction | 15 |
jhm variants | 15 |
heterologous genes | 15 |
second orf | 15 |
blot using | 15 |
regulatory proteins | 15 |
taq polymerase | 15 |
transcription mechanism | 15 |
acid residue | 15 |
pharmacia biotech | 15 |
protein trafficking | 15 |
factor receptor | 15 |
evidence indicates | 15 |
fusion core | 15 |
standard jhm | 15 |
readily detected | 15 |
nucleotide identity | 15 |
pseudotyped vsvs | 15 |
density gradient | 15 |
laser scanning | 15 |
relative amount | 15 |
inflammatory cytokine | 15 |
co incubator | 15 |
coronavirus avian | 15 |
preliminary experiments | 15 |
beaudette strain | 15 |
methionine cysteine | 15 |
apoptosis induced | 15 |
rna complex | 15 |
metabolic labeling | 15 |
infected glial | 15 |
di vector | 15 |
sucrose density | 15 |
severe respiratory | 15 |
structural features | 15 |
two overlapping | 15 |
mhv mrnas | 15 |
neutralizing epitope | 15 |
convalescent serum | 15 |
moloney murine | 15 |
intermediate compartment | 15 |
salt bridges | 15 |
sg mrnas | 15 |
linked immunosorbent | 15 |
nsp dmid | 15 |
virus family | 15 |
flag antibody | 15 |
ts phenotype | 15 |
gene fragments | 15 |
flow cytometric | 15 |
data shown | 15 |
virus budding | 15 |
transferrin receptor | 15 |
mice lacking | 15 |
rna isolated | 15 |
labeled cells | 15 |
vol vol | 15 |
virus inoculum | 15 |
bromophenol blue | 15 |
recombinant proteins | 15 |
new zealand | 15 |
one nucleotide | 15 |
transcripts derived | 15 |
irf phosphorylation | 15 |
reverse transcribed | 15 |
polyethylene glycol | 15 |
deficient covs | 15 |
loading control | 15 |
sequence alignments | 15 |
fecal samples | 15 |
silent mutations | 15 |
data obtained | 15 |
comparative sequence | 15 |
type envelope | 15 |
membrane structures | 15 |
pcv viral | 15 |
antiviral drugs | 15 |
viral vectors | 15 |
thymidine kinase | 15 |
rna probe | 15 |
passage virus | 15 |
cholesterol depletion | 15 |
data suggested | 15 |
virus genomic | 15 |
serine residues | 15 |
green fluorescence | 15 |
also binds | 15 |
alpha production | 15 |
microarray analysis | 15 |
extracellular signal | 15 |
recombinant ibv | 15 |
polyclonal rabbit | 15 |
adapted ibv | 15 |
based vaccine | 15 |
viral cell | 15 |
nt downstream | 15 |
effector cells | 15 |
single nucleotide | 15 |
two primers | 15 |
minor ectodomain | 15 |
preferential requirement | 15 |
jev ns | 15 |
mutagenesis studies | 15 |
stable expression | 15 |
susceptible cells | 15 |
ucuaa copies | 15 |
phenylmethylsulfonyl fluoride | 15 |
immune signaling | 15 |
neural stem | 15 |
nude mouse | 15 |
synthetic peptide | 15 |
stem loop | 15 |
selection pressures | 15 |
hamster kidney | 15 |
type strain | 15 |
acetic acid | 15 |
previously characterized | 15 |
cov neutralizing | 15 |
systemically infect | 15 |
phylogenetic trees | 15 |
rna intermediates | 15 |
synthetic oligonucleotide | 15 |
orf iv | 15 |
rna pseudoknot | 15 |
site within | 15 |
virus virulence | 15 |
sequenced using | 15 |
international committee | 15 |
ribonucleic acid | 15 |
ts recombinants | 15 |
virus containing | 15 |
plasmid dnas | 15 |
cycle arrest | 15 |
crispr cas | 15 |
log pfu | 15 |
four major | 15 |
phosphate buffered | 15 |
susceptible mice | 15 |
dependent phosphorylation | 15 |
infected protoplasts | 15 |
phosphorylation status | 15 |
slippery sequences | 15 |
putative rna | 15 |
strongly suggest | 15 |
different viral | 15 |
muns cleavage | 15 |
replicative intermediate | 15 |
acting elements | 15 |
primary infection | 15 |
coronavirus mrnas | 15 |
economic losses | 15 |
three cysteine | 15 |
line dbt | 15 |
transmembrane domains | 15 |
transferred onto | 15 |
protein suppresses | 15 |
structural elements | 15 |
tgev orf | 15 |
regulating sequences | 15 |
antiviral drug | 15 |
dna sequences | 15 |
virus expression | 15 |
coronavirus defective | 15 |
zoster virus | 15 |
lower panel | 15 |
subgenomic negative | 14 |
vectors based | 14 |
binding domains | 14 |
arterivirus replication | 14 |
small amounts | 14 |
medial golgi | 14 |
transmembrane glycoprotein | 14 |
virus replicase | 14 |
recombinant mbp | 14 |
three washes | 14 |
sham inoculated | 14 |
restriction enzymes | 14 |
viral pathogenicity | 14 |
central role | 14 |
mg kg | 14 |
vitro system | 14 |
points post | 14 |
ibv genome | 14 |
polyribosomal rna | 14 |
optical density | 14 |
protease cleavage | 14 |
coomassie blue | 14 |
within orf | 14 |
signaling molecules | 14 |
recombinant rna | 14 |
disease control | 14 |
antigenic domains | 14 |
vsvs pseudotyped | 14 |
ringspot virus | 14 |
within nsp | 14 |
i ii | 14 |
recombinant baculovirus | 14 |
terminal heptad | 14 |
based vectors | 14 |
rhesus monkeys | 14 |
induces cell | 14 |
associated ha | 14 |
complex class | 14 |
sds lysis | 14 |
produce infectious | 14 |
selective ion | 14 |
dna ligase | 14 |
cornell university | 14 |
major determinant | 14 |
terminal signal | 14 |
salivary glands | 14 |
cells also | 14 |
efficient virus | 14 |
infectious centers | 14 |
immunofluorescence staining | 14 |
coronavirus mrna | 14 |
cdna probes | 14 |
strictly conserved | 14 |
mosquito cells | 14 |
molecular mechanism | 14 |
rna vector | 14 |
enters cells | 14 |
viruses may | 14 |
cd expression | 14 |
cell proteins | 14 |
encephalomyocarditis virus | 14 |
interstitial pneumonia | 14 |
reporter system | 14 |
mhv mrna | 14 |
research institute | 14 |
hydrophobic domain | 14 |
recently identified | 14 |
world arenaviruses | 14 |
phage clones | 14 |
days postinoculation | 14 |
led us | 14 |
viral factories | 14 |
well characterized | 14 |
chimeric viruses | 14 |
nsp dfl | 14 |
coronavirus isolates | 14 |
specific genes | 14 |
protein concentration | 14 |
sequence encoding | 14 |
vaccine development | 14 |
restrictive temperature | 14 |
nitrocellulose membranes | 14 |
containing rnas | 14 |
plasmid expressing | 14 |
derived ahsv | 14 |
cdna library | 14 |
study demonstrated | 14 |
influenza vaccine | 14 |
viral cdna | 14 |
glass slides | 14 |
promoter sequences | 14 |
viral transcription | 14 |
uv target | 14 |
mabs specific | 14 |
small di | 14 |
box rna | 14 |
potential cleavage | 14 |
reporter assay | 14 |
induced demyelination | 14 |
days later | 14 |
kidney cell | 14 |
pvdf membrane | 14 |
benthamiana protoplasts | 14 |
transcripts containing | 14 |
virus specific | 14 |
also determined | 14 |
regulated kinase | 14 |
mhv clpro | 14 |
vaccinia viruses | 14 |
key role | 14 |
take place | 14 |
bnip promoter | 14 |
immunosorbent assay | 14 |
sequence motifs | 14 |
pulse labeling | 14 |
systematic assembly | 14 |
long noncoding | 14 |
master mix | 14 |
tgev genome | 14 |
binding properties | 14 |
fold dilutions | 14 |
induced demyelinating | 14 |
reaction products | 14 |
fold reduction | 14 |
significant decrease | 14 |
kozak context | 14 |
respiratory viruses | 14 |
veterinary medicine | 14 |
family arteriviridae | 14 |
strain vr | 14 |
assays using | 14 |
dependent pathway | 14 |
virus yield | 14 |
result indicates | 14 |
control animals | 14 |
pcr reaction | 14 |
tgev particles | 14 |
biological activities | 14 |
world alphaviruses | 14 |
mechanisms underlying | 14 |
experimental conditions | 14 |
feline enteric | 14 |
tam receptors | 14 |
poliovirus infection | 14 |
suckling mouse | 14 |
standard procedures | 14 |
coronavirus papain | 14 |
memory cd | 14 |
also indicated | 14 |
simian hemorrhagic | 14 |
two novel | 14 |
brain homogenates | 14 |
helpful discussions | 14 |
oligonucleotide fingerprinting | 14 |
data show | 14 |
units ml | 14 |
murine cns | 14 |
functional class | 14 |
scanning confocal | 14 |
transcribed rna | 14 |
primary human | 14 |
left indicate | 14 |
rough endoplasmic | 14 |
highly attenuated | 14 |
interferon response | 14 |
wheat germ | 14 |
studies showed | 14 |
sars vaccine | 14 |
two rna | 14 |
infectious clones | 14 |
efficient ribosomal | 14 |
different viruses | 14 |
different strains | 14 |
early infection | 14 |
humoral immune | 14 |